The effects of Alzheimer's disease-related amyloidogenic peptides on inositol 1,4,5-trisphosphate receptormediated Ca 2؉ mobilization were examined in Xenopus laevis oocytes. Intracellular Ca 2؉ was monitored by electrophysiological measurement of the endogenous Ca 2؉ -activated Cl ؊ current. Application of a hyperpolarizing pulse released intracellular Ca 2؉ in oocytes primed by pre-injection of a non-metabolizable inositol 1,4,5-trisphosphate analogue. The carboxyl terminus of the amyloid precursor protein inhibited inositol 1,4,5-trisphosphate receptor-mediated intracellular Ca 2؉ release in a dose-dependent manner. Equimolar ␤-amyloid peptides A␤ 1-40 or A␤ 1-42 had no effect, and whereas a truncated carboxyl terminus lacking the A␤ domain was equipotent to the full-length one, a carboxyl terminus fragment lacking the NPTY sequence was less effective than the full-length fragment. The inhibition induced by the carboxyl terminus was not associated with the block of the Ca 2؉ -dependent Cl ؊ channel itself or compromised Ca 2؉ influx. We conclude that the carboxyl terminus of the amyloid precursor protein inhibits inositol 1,4,5-trisphosphate-sensitive Ca 2؉ release and could thus disrupt Ca 2؉ homeostasis and that the carboxyl terminus is much more effective than the ␤-amyloid fragments used. By perturbing the coupling of inositol 1,4,5-trisphosphate and Ca 2؉ release, the carboxyl terminus of the amyloid precursor protein can potentially be involved in inducing the neural toxicity characteristic of Alzheimer's disease.
The effects of Alzheimer's disease-related amyloidogenic peptides on inositol 1,4,5-trisphosphate receptormediated Ca 2؉ mobilization were examined in Xenopus laevis oocytes. Intracellular Ca 2؉ was monitored by electrophysiological measurement of the endogenous Ca 2؉ -activated Cl ؊ current. Application of a hyperpolarizing pulse released intracellular Ca 2؉ in oocytes primed by pre-injection of a non-metabolizable inositol 1,4,5-trisphosphate analogue. The carboxyl terminus of the amyloid precursor protein inhibited inositol 1,4,5-trisphosphate receptor-mediated intracellular Ca 2؉ release in a dose-dependent manner. Equimolar ␤-amyloid peptides A␤ or A␤ 1-42 had no effect, and whereas a truncated carboxyl terminus lacking the A␤ domain was equipotent to the full-length one, a carboxyl terminus fragment lacking the NPTY sequence was less effective than the full-length fragment. The inhibition induced by the carboxyl terminus was not associated with the block of the Ca 2؉ -dependent Cl ؊ channel itself or compromised Ca 2؉ influx. We conclude that the carboxyl terminus of the amyloid precursor protein inhibits inositol 1,4,5-trisphosphate-sensitive Ca 2؉ release and could thus disrupt Ca 2؉ homeostasis and that the carboxyl terminus is much more effective than the ␤-amyloid fragments used. By perturbing the coupling of inositol 1,4,5-trisphosphate and Ca 2؉ release, the carboxyl terminus of the amyloid precursor protein can potentially be involved in inducing the neural toxicity characteristic of Alzheimer's disease.
Alzheimer's disease (AD)
1 is a progressive and fatal neurodegenerative disease characterized by amyloid plaques and neurofibrillary tangles (for a review, see Ref. 1) . These plaques are associated with degenerating neuronal processes and consist primarily of fibrillar aggregates of ␤-amyloid protein (A␤). Although A␤ fragments are the main component of amyloid plaques and have been shown to damage or kill cultured neurones (for a review, see Ref.
2), A␤ may not be the sole neurotoxic component of the amyloid precursor protein (APP). For example, A␤ peptide deposition has been observed without accompanying neurodegeneration (3) (4) (5) . Another amyloidogenic fragment, the carboxyl terminus (CT) of APP, which is composed of 99 -105 amino acid residues containing the complete A␤ sequence, also appears to be toxic to neurones (6, 7) . CT has been found not only in presynaptic terminals of rodent entorhinal neurones (8) but also in paired helical filaments (9) , in senile plaques (10) , in microvessels (11) (12) (13) , in choroid plexus from human brain in AD, in the white matter of Down's syndrome brains (14) , and in both cytosol and media of lymphoblastoid cells obtained from patients with early-or lateonset familial AD (15) and Down's syndrome (16) . A transgenic mouse model expressing CT exhibited neuropathology very similar in many respects to that of AD, especially as regards age-dependent neuronal and synaptic degeneration (17) and spatial-learning deficits and electrophysiological alterations that suggested impairment of synaptic plasticity (18) . A 31-amino acid carboxyl-terminal fragment of APP (CT31) generated from CT by caspase-9 cleavage was reported to have a pro-apoptotic effect and to mainly contribute to the CT toxicity in neuronal cells. Both CT31 and activated caspase-9 were present in the brains of AD patients but not in control brains (19) . These findings together indicate that CTs themselves may also contribute to the neurodegenerative processes in vivo not only as a precursor to make A␤. Earlier studies showed that A␤-bearing CTs were released from several different cells and/or were more easily released from the damaged neurons into the media or extracellular fluid (20 -22) . Recent data has shown the presence of CT in the nuclei (23) and the transcriptively active complex of CT with Fe65 and histone acetyltransferase, Tip60 (24) . These findings suggest that CT plays important roles in delayed neurodegeneration via transcriptional regulation. Our previous study also demonstrated that CT fragments without A␤ and the transmembrane domain may also exert toxicity in nerve growth factor-differentiated PC12 cells (25) . CT can also contribute to stimulation of inflammatory processes linked to delayed neurodegeneration in AD (26 -28) .
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§ (34, 35) . In addition, Yao and Parker (36) showed that application of a hyperpolarizing pulse to Xenopus oocytes pre-injected with an enzymeresistant IP 3 analogue, D-3-deoxy-3-fluoro-myo-inositol 1,4,5-trisphosphate (3-F-IP 3 ), induced a current that represented Ca 2ϩ release from IP 3 -sensitive stores. We have adopted this protocol to study the effect of amyloidogenic peptides on the IP 3 pathway.
EXPERIMENTAL PROCEDURES
Preparation of Recombinant CT105 and A␤-Recombinant CT105 was prepared on the basis of human APP770 cDNA as described previously (37) . Briefly, the expression plasmid pCS-CT105 was constructed by ligating the 704-bp BglII-ClaI fragment excised from pSP65-APP770 into ptrpSF9, digested with BglII and SmaI, treated with calf intestinal alkaline phosphatase, and transformed into Escherichia coli XL1-Blue. CT105 peptide (M r 14,242) was purified by a combination of urea solubilization and ion exchange chromatography and then subjected to dialysis against 10 mM Tris-HCl (pH 7.4) followed by lyophilization. To rule out the effect of possible co-purified contaminating factors, groups incubated with polymixin B sulfate were compared with non-treated ones. We confirmed that these are not significantly different. A␤ was purchased from Sigma-Aldrich Co. Ltd. (Dorset, UK). A␤ , A␤ , and CT were dissolved in distilled water to make 100 M stock solutions and incubated at 37°C for 6 days.
Construction of Truncated CT Peptides-To determine which region is the active domain responsible for the effect on IP 3 signaling of CT, we have generated truncated carboxyl-terminal fragments of APP. Because A␤, the transmembrane portion, and the NPTY sequence in the cytoplasmic tail are believed to be important in mediating toxic effects of CT peptide, constructs without these domains were generated using the PCR-amplified strategy and the GST fusion protein strategy as described earlier (25) . Briefly, they were cloned from pSP65-APP770 by PCR using oligonucleotides complementary to corresponding position (28) . For the construction of plasmids encoding GST fusion proteins, BamHI/XhoI fragment of the PCR-generated fragments was cloned into the BamHI/XhoI site of pGEX 4T-1. We have prepared the following constructs: GST-CT 46 (649 -695) without A␤ and transmembrane (TM) domain (CTdA␤/TM) and GST-CT 86 (597-683) without NPTY domain (CTdNPTY). These final PCR constructs were confirmed by automated DNA sequencing. These recombinant GST-CTs of APP were purified with a combination of urea solubilization and ion exchange chromatography.
Oocyte Preparation and Solutions-X. laevis oocytes were prepared and defolliculated as described previously (38) . Defolliculated oocytes were stored in incubation medium at 19°C for several days. Composition of the incubation medium was (in millimolar): NaCl, 88.0; KCl, 1.0; CaCl 2 , 0.41; NaHCO 3 , 2.5; MgSO 4 , 0.82; and Ca(NO 3 ) 2 , 0.33, penicillin and streptomycin, 10 g/ml each; gentamicin sulfate, 0.1 mg/ml; pH 7.5. Unless otherwise noted, oocytes were continually perfused with Ringer's solution at room temperature (18 -20°C) during recording. In the case of thapsigargin pretreatment, oocytes were incubated in Ca 2ϩ -free medium containing 1 M thapsigargin overnight at 19°C.
Composition of the normal Ringer's solution was (millimolar): NaCl, 120; KCl, 2; CaCl 2 , 1.8; HEPES, 5; pH 7.3. Ca 2ϩ -free medium was made by omitting CaCl 2 and adding 5 mM MgCl 2 together with 1 mM EGTA (36) . Most chemicals were purchased from Sigma-Aldrich Company Ltd. (Dorset, UK). 3-F-IP 3 , purchased from CN Biosciences UK (Nottingham, UK), was dissolved in distilled water at 35 M. 3-F-IP 3 is about equipotent to IP 3 in liberating intracellular Ca 2ϩ but cannot be converted to inositol 1,3,4,5-tetrakisphosphate by the action of 3-kinases and thus stimulates IP 3 receptors continuously (39) . Thapsigargin (Alomone Labs Ltd., Jerusalem, Israel) was dissolved in dimethyl sulfoxide (Me 2 SO). The final concentration of Me 2 SO in the Ca 2ϩ -free medium was 0.1%. The dissolved chemical and peptides were kept at Ϫ20°C until use.
Microinjection-Pulled injection pipette3-00-2s (03-G/XL, Drummond, Broomal, PA; tip diameters, 10 -15 m) were back-filled with the 3-F-IP 3 solutions and attached to an oocyte injector (Drummond). 46 nl of solution was injected into each oocyte. Injected oocytes were kept for about 30 min in an incubator at 19°C, except for experiments on transient current responses. The latter were induced directly by 3-F-IP 3 injections, under voltage clamp, using a pneumatic pico-pump (WPI, Sarasota, FL). A holding potential of Ϫ40 mV was used in these experiments.
In the main body of experiments, A␤ 1-40 , A␤ , full-length CT or the truncated fragments were injected into oocytes which had been "primed" previously for 30 min with 3-F-IP 3 (at 150 nM intracellular concentration). Injection of the peptides was achieved either with the oocyte injector (Drummond) or with the pico-pump, dependent on the experimental set up. For experiments using the pico-pump, the volume of the injected peptide solution was calibrated before the start of the experiments. For a pre-set pressure (20 p.s.i.), the duration was adjusted to give the same ejected volume of liquid (46 nl Electrophysiology-Conventional two-electrode methodologies were performed with a voltage-clamp amplifier (GeneClamp 500B, Axon Instruments, Foster City, CA). Resistances of the voltage-measuring electrodes filled with 2.5 M KCl were in the range 1-3 M⍀, whereas current-measuring electrodes had resistances of 0.4 -1 M⍀. Stimulation and data acquisition were controlled by pClamp 6.02 software (Axon Instruments) via a Digidata 1200 interface (Axon Instruments). Recorded data were stored on an IBM computer and analyzed in pClamp 6.02 package. Two types of membrane currents were recorded: 1) Fast, transient currents induced directly by 3-F-IP 3 injection. For recording the transient current (I t ) induced directly by 3-F-IP 3 itself, the compound was injected into oocytes under voltage clamp (Ϫ40 mV), and the resulting currents were monitored for ϳ20 min. 2) Late currents induced by membrane hyperpolarization in oocytes pre-injected with 3-F-IP 3 . The delayed membrane currents (T in ) were recorded as follows: (i) An oocyte pre-injected with 3-F-IP 3 was incubated for 30 min and transferred to the recording chamber. (ii) The oocyte was voltageclamped at a holding potential of 0 mV to keep the driving force of Ca 2ϩ influx at a low level. (iii) A hyperpolarizing pulse was applied from 0 mV to Ϫ110 mV for 4.5 s, and the current response was recorded. The current response recorded before the peptide injection was used as the control. (iv) A peptide was injected with the pico-pump or oocyte injector. (v) The same hyperpolarizing pulse was applied to the oocyte 10 min following peptide injection. The resulting response was compared with its own pre-injection control. The percentage residual current was expressed as [(post-injection amplitude/pre-injection amplitude) ϫ 100].
Data Analysis-All data have been presented as means Ϯ S.E. of the means (S.E.). The number of measurements given (n) represents different oocytes; the number of batches, i.e. toads used (N) for a given experiment, is also indicated. Data were analyzed using a statistics package, SAS/6.03 (SAS Institute, Cary, NC). Effect of a given peptide on current amplitude was analyzed by one-way ANOVA, after all the percentage data were transformed to logarithmic values. A Tukey test was used for multiple comparisons. Wilcoxon test (non-parametric) was used for comparison of two groups. Correlation coefficients were determined by non-parametric Spearman test. Statistical significance was considered at the following levels: p Ͻ 0.05 ( †), p Ͻ 0.01 (*), p Ͻ 0.001 (**), p Ͻ 0.0001 (***), and p Ͻ 0.00001 (****). 3 (1 M) into oocytes held at Ϫ40 mV caused a biphasic inward current: A fast, transient component (I t ), followed by a slow phase with typical oscillations (Fig. 1A) . This response
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pattern was similar to those induced by IP 3 or 3-F-IP 3 in previous studies on Xenopus oocytes (36, 40, 41) . This confirmed that the IP 3 system was functioning normally.
Hyperpolarization-induced Membrane Currents in 3-F-IP 3 -injected
Oocytes-Oocytes injected with 3-F-IP 3 (150 nM) were incubated for a further 30 min and then a hyperpolarizing pulse (0 to Ϫ110 mV) was applied under voltage clamp. This generated a slow "hump-like" inward current (T in , Parker and Miledi (42)) (Fig. 1B) . Water-injected control oocytes showed only leakage currents without T in (Fig. 1C) . The reversal potential of T in was about Ϫ22 mV (n ϭ 3), similar to the value reported previously for the endogenous Ca 2ϩ -dependent Cl (Fig. 1, D versus E) . This effect was reversible, with the current recovered in normal Ringer's solution containing 1.8 mM Ca 2ϩ (Fig. 1F) . We also tested whether T in could be mediated exclusively by Ca 2ϩ influx. Thapsigargin (1 M) was used to deplete Ca 2ϩ stores and set up capacitative Ca 2ϩ entry (43) . No T in current could be observed in such oocytes using the standard protocol (data not shown). This confirmed, under our experimental conditions, T in was not simply generated by Ca 2ϩ entering from outside. These characteristics taken together are consistent with the T in current representing a Cl Ϫ current activated by Ca 2ϩ released from IP 3 -sensitive stores by the triggering action of hyperpolarization-induced Ca 2ϩ influx, as in the study of Yao and Parker (36) .
Inhibitory Effect of CT on T in
Following a control (pre-injection) recording of T in in oocytes primed with 3-F-IP 3 , water (as vehicle control) or an amyloidogenic fragment of APP (A␤ , A␤ 1-42 , or CT) was applied intracellularly. Experiments, in which the oocytes were injected with distilled water alone, showed that T in was stable and that the post-injection amplitudes were not much different from those of pre-injection controls (residual current ϭ 96.5 Ϯ 4.8%; n ϭ 18/n ϭ 4; p Ͼ 0.05; Figs. 2A and 3A) . Application of either A␤ or A␤ 1-42 (0.22-3.0 M for both) had no significant effect on T in (n ϭ 8 for each; Figs. 2B, 2C, and 3A). In contrast, injection of CT peptide was very effective in suppressing T in (Figs. 2D and 3A) . The inhibitory effect of CT peptide on T in was dose-dependent (Fig. 4) . The concentration of CT peptide that induced half-maximal inhibition of T in was about 0.4 M.
We also investigated if CT would inhibit I t induced directly by 3-F-IP 3 injection. 3-F-IP 3 (1 M) typically evoked peak inward currents of 50 -350 nA. There was no statistically significant effect on the peak inward current when 1.3 M CT (a concentration that consistently inhibited T in ) was co-injected with 3-F-IP 3 (n ϭ 13/n ϭ 3; p Ͼ 0.1). In addition, the reduction of T in was not overcome by 10-or 100-fold higher concentration of 3-F-IP 3 (i.e. 1.5 and 15 M, respectively; data not shown). In addition, we tested whether IP 3 re-injection could evoke the current following the initial block by CT. We could not find any recovery of T in in this condition (data not shown).
Comparison of Inhibitory Effect of CT and the Truncated CT Peptides on T in -To
explore the active part of the CT domain responsible for its inhibitory effects on T in , we made truncated CT peptides, CTdNPTY and CTdA␤/⌻M. Water, 1.2 M GST, CT, or each GST-conjugated, truncated CT peptide was applied intracellularly, after checking T in in oocytes primed with 3-F-IP 3 . CTdNPTY suppressed T in less effectively than full-length CT injection (residual current ϭ 57.2 Ϯ 10.3%, n ϭ 7; p Ͻ 0.05; Fig. 3B ), whereas CTdA␤/TM showed no significant difference (residual current ϭ 19.3 Ϯ 10.3%, n ϭ 7; Fig. 3B ) at the same concentration. The control oocytes injected with GST or water showed stable T in (residual current of GST ϭ 101.0 Ϯ 15.5%, n ϭ 7; p Ͼ 0.05; residual current of water ϭ 96.5 Ϯ 4.8%, n ϭ 18; p Ͼ 0.05; Fig. 3A) . These results show that the YENPTY domain in the cytoplasmic tail seems to have a more crucial role in inhibiting IP 3 signaling rather than the A␤ or TM domains.
Lack of Effect of CT on Capacitative Ca 2ϩ Entry or Ca 2ϩ -dependent Cl
Ϫ Channels-To eliminate the possibility that CT 
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could compromise capacitative Ca 2ϩ entry, oocytes that had been pre-treated with thapsigargin overnight (in the absence of extracellular Ca 2ϩ ), to set up capacitative Ca 2ϩ entry (44), were injected with 1.3 M CT. Current responses to hyperpolarizing pulses were 646 Ϯ 142 nA before, compared with 590 Ϯ 157 nA following CT injection (p ϭ 0.18, n ϭ 11/n ϭ 3; Fig. 5 ). In addition, thapsigargin treatment is known to lengthen the time-to-peak of T in (41) . We therefore measured the time-topeak of T in before and following 1.3 M CT injection (1245 Ϯ 196 ms versus 1134 Ϯ 150 ms, respectively). The values were not significantly different (p ϭ 0.19; n ϭ 12). Together, these results are consistent with CT having no significant effect on capacitative Ca 2ϩ entry. To elucidate whether the inhibitory effect of CT involved directly the Ca 2ϩ -activated Cl Ϫ channels, we compared the decay time courses of T in before and after CT injection in oocytes in which CT reduced, but did not abolish, the peak T in current (see later). Current decay could be fitted with a single exponential of which the time constant () did not change significantly following CT injection ( ϭ 1024 Ϯ 265 versus 964 Ϯ 156 ms, before and after CT, respectively, n ϭ 16/n ϭ 4; p Ͼ 0.4; Fig. 6 ).
In conclusion, the inhibitory effect of CT on Ca 2ϩ release was most likely due to suppression of IP 3 -sensitive Ca 2ϩ release from internal stores, rather than any effect on capacitative Ca 2ϩ entry or Ca 2ϩ -activated Cl Ϫ current.
Relation of Time to Peak of T in and Inhibitory Effect of CT-
We explored the relationship between the time-to-peak of T in   FIG. 3 . A, normalized mean amplitudes of residual T in after injection of water or 2.2 M amyloidogenic fragments. Residual currents (%) were calculated by dividing the peak amplitude of T in after injection with that of the respective control T in (i.e. (post-injection T in ϫ 100)/(preinjection T in )). One way-ANOVA and a Tukey test were performed for statistical comparisons with the water-injected control (***, p Ͻ 0.0001). The data for each condition represent the mean of eight oocytes; the value for water control was obtained from 12 oocytes. Error bars denote S.E. B, normalized mean amplitudes of residual T in after injection of water, GST, 1.22 M CT, or equimolar truncated CT peptides. Residual currents were determined as described above. Student's t test was performed for comparison with GST control (*, p Ͻ 0.01; CTdNPTY (ϩ) indicates p Ͻ 0.05). 
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(measured before CT injection) and the residual peak current recorded after CT injection expressed as a percentage of the original amplitude. Fig. 7 shows that there was a strong inverse correlation between the time-to-peak prior to CT injection and the residual current (correlation coefficient ϭ Ϫ0.78; p Ͻ 0.001). This suggested that oocytes with slower T in were more sensitive to CT. In other words, when Ca 2ϩ influx (derived from the membrane hyperpolarization) needed to trigger T in was greater, as indicated by the time-to-peak of T in , the suppressing effect of CT was bigger. DISCUSSION We investigated the effects of amyloidogenic fragments of APP on the IP 3 pathway in X. laevis oocytes using the Ca 2ϩ -activated Cl Ϫ (T in ) current as an indicator of [Ca 2ϩ ] i . The main conclusion is that CT peptide, but not the A␤ fragments, inhibits Ca 2ϩ release from intracellular Ca 2ϩ stores when activated by an IP 3 analogue and triggered by hyperpolarization-induced Ca 2ϩ influx. T in required the presence of extracellular Ca 2ϩ to be triggered, because it was abolished in Ca 2ϩ -free medium (Fig. 1, E  and F) . If T in were to be mediated exclusively by Ca 2ϩ entry, however, it should have persisted in oocytes when capacitative Ca 2ϩ entry was induced by use of thapsigargin (43) . The absence of T in in thapsigargin-treated oocytes suggested that the current was not dependent upon Ca 2ϩ influx alone. It was concluded, therefore, that entry of Ca 2ϩ induced by membrane hyperpolarization triggered T in , as a consequence of Ca 2ϩ release from IP 3 -sensitive Ca 2ϩ stores in continuous presence of IP 3 . This is consistent with the results of Yao and Parker (36) . It should be noted, however, that under conditions associated with more "complex" second-messenger associated events (e.g. 5-hydroxytryptamine receptor activation (36)), there is evidence that T in can be activated by interaction of Ca 2ϩ influx and Cl Ϫ channels, in a pathway that bypasses the need for intracellular Ca 2ϩ release. However, under our experimental conditions, this was clearly not the case.
Enhanced depletion of the Ca 2ϩ store obtained by high (1.5 M) concentration of 3-F-IP 3 did not result in any significant increase of T in amplitude. This ruled out the possibility that T in was a simple delayed release of Ca 2ϩ from incompletely depleted Ca 2ϩ stores. However, it is possible that the IP 3 -dependent Ca 2ϩ release could involve a refilling mechanism occurring after Ca 2ϩ store depletion. Control experiments, in which oocytes were injected with distilled water alone, showed that T in was stable and that the post-injection amplitude was not much different from the preinjection amplitude (Figs. 3A and 4) . Intracellular application of the CT peptide strongly attenuated T in , whereas A␤ 1-40 and A␤ had no significant effect under identical experimental conditions (Figs. 3, B-D, and 4A ). In addition, the reduction of T in was not overcome by 10-or 100-fold higher concentration of 3-F-IP 3 (i.e. 1.5 and 15 M, respectively, data not shown). In addition, we tested whether IP 3 re-injection could evoke the current following the initial block by CT. We could not find any recovery of T in in this condition (data not shown). These experiments indicate that CT inhibits T in by altering the IP 3 -induced receptor-signaling pathway rather than simply by blocking IP 3 receptor directly.
The deletion studies showed that YENPTY sequence, which is known to have a role in intracellular sorting (24) , rather than the A␤ or TM domains, may at least in part, be responsible for the attenuation of IP3 induced signal (Fig. 3B) .
Interestingly, injection of the CT peptide had no effect on the size of I t . At present, the reasons for this are unclear, because both I t and T in are dependent on IP 3 . However, the two events are distinct in that (i) I t is an immediate event following IP 3 injection, whereas T in takes many minutes to develop and (ii) I t , unlike T in , is not dependent upon extracellular Ca 2ϩ (45) . Thus, possible differences in the intracellular events controlling these two discrete events may explain their distinct sensitivity to CT.
The inhibitory effect of CT on T in was concentration-dependent, with the half-maximal effect occurring at about 0.4 M (Fig. 4) . This is in the range of CT concentrations found previ- . 3 ) and time-to-peak (log scale). The inhibitory effect of CT on T in was enhanced in oocytes displaying longer time-to-peak before CT peptide injection. A non-parametric Spearson test showed that there is a strong inverse correlation between the two data sets (correlation coefficient ϭ Ϫ0.78; p Ͻ 0.001).
Inhibition of IP 3 -sensitive Ca 2ϩ Release by CT Peptide of APP 20261
ously to be toxic to oocytes (46) and to a variety of mammalian cells, including neurones (7) . Several possible mechanisms were tested to elucidate the one or more steps involved in the inhibitory effect of CT on T in . In particular, the possible effects of CT on 1) capacitative Ca 2ϩ entry, 2) the Ca 2ϩ -activated Cl Ϫ channel, or 3) the cytoplasmic Ca 2ϩ level, were evaluated. Compromised Ca 2ϩ entry, preventing Ca 2ϩ release from intracellular stores, was unlikely to be involved, because capacitative Ca 2ϩ entry induced by pre-treatment of thapsigargin did not change significantly after CT injection (Fig. 5) and CT had no effect on the length of the time-to-peak of T in. This is in agreement with recent work by Yoo et al. (47) , who found that neither A␤ 1-42 nor full-length ␤APP had any effect on capacitative Ca 2ϩ entry in Chinese hamster ovary cells. It was possible that CT affected the Ca 2ϩ -dependent Cl Ϫ channels directly. However, the decay time constant () of T in measured before and after CT injection did not change (Fig. 6) . Furthermore, oscillatory currents due to the Ca 2ϩ -activated Cl Ϫ current were observed in oocytes after CT injection, consistent with lack of effect of CT on the Cl Ϫ channel (46 (49, 50) . If this mechanism occurred under our experimental conditions, however, the capacitative Ca 2ϩ entry induced by 3-F-IP 3 or thapsigargin should have increased after CT injection. Such an increase was not observed (Figs. 2D and 5) . Therefore, increased Ca 2ϩ influx cannot account for the inhibitory effect of CT on IP 3 -sensitive Ca 2ϩ release. However, we cannot rule out the possibility that the Ca 2ϩ influx enhanced by CT was large enough to block Ca 2ϩ release through IP 3 receptor channels, but the change was too small to be detected by electrophysiological recording. This possibility remains to be investigated further.
We tested whether CT would affect directly Ca 2ϩ release from IP 3 -sensitive Ca 2ϩ stores. The analysis shown in Fig. 7 revealed a strong, inverse relationship between time-to-peak of T in measured before CT injection and residual current amplitude after CT injection. The response to IP 3 varied greatly from oocyte to oocyte, possibly due to the differences in the number and spatial distribution of IP 3 receptors (45, 51) . Oocytes, which were highly sensitive to 3-F-IP 3, would deplete their Ca 2ϩ stores more in response to a given concentration of 3-F-IP 3 , compared with relatively insensitive oocytes. CT more potently blocked T in (Ca 2ϩ release from IP 3 -sensitive stores) in oocytes displaying longer time-to-peak.
Two existing hypothesis can be adopted to explain the relationship between time-to-peak and sensitivity of each oocyte to IP 3 , as follows: First, there is the steady-state model. It has been suggested that Ca 2ϩ release is controlled by the intraluminal Ca 2ϩ level within Ca 2ϩ stores (52) . The steady-state model considered that decreasing the Ca 2ϩ content of the stores would slow down further the Ca 2ϩ release until it stopped when the level of luminal Ca 2ϩ fell to a low concentration (53). Consequently, "sensitive" oocytes would have less full Ca 2ϩ stores after injection of 3-F-IP 3 and would need more Ca 2ϩ refilling to reach a certain threshold for Ca 2ϩ release, which may result in delayed T in (i.e. longer time-to-peak), as found (Fig. 7) . Second, there is the feedback model. Feedback inhibition of the IP 3 receptor by cytosolic Ca 2ϩ would limit further release of Ca 2ϩ , and recovery of sensitivity to IP 3 would follow the subsequent decline of cytosolic Ca 2ϩ as the latter was re-sequestered (54, 55) . Accordingly, oocytes highly sensitive to 3-F-IP 3 would have more Ca 2ϩ liberated by injection of 3-F-IP 3 . Such oocytes could take longer time to sequester Ca 2ϩ to a non-blocking level of [Ca 2ϩ ] i and this may result in delayed T in . Thus, the time-to-peak can be considered as a measure of the IP 3 sensitivity of each oocyte. Ca 2ϩ release in highly sensitive oocytes (where a large portion of Ca 2ϩ store was exhausted by the 3-F-IP 3 ) was inhibited more by CT. Such a correlation would arise as a result of CT directly suppressing IP 3 -sensitive Ca 2ϩ release rather than one or more other auxiliary mechanisms. Hence, the inverse relationship found is consistent with CT inhibition being specific to the Ca 2ϩ release mechanism from IP 3 -sensitive Ca 2ϩ stores. However, CT did not appear to inhibit directly the binding of 3-F-IP 3 to IP 3 receptors or compete with 3-F-IP 3 for IP 3 binding sites, because there was no significant effect of CT on I t when co-injected with 3-F-IP 3 , and high concentrations of 3-F-IP 3 could not overcome the CTinduced block. CT was most likely to uncouple the triggering action of Ca 2ϩ influx from induction of the IP 3 -sensitive Ca 2ϩ release. It remains to be determined whether such an uncoupling effect occurs in vivo and whether it could lead to any long-term effect. In overall conclusion, we have shown that the CT fragment of ␤APP, but not the A␤ fragments, suppresses Ca 2ϩ release from IP 3 -sensitive Ca 2ϩ stores triggered by extracellular Ca 2ϩ entry in the Xenopus oocyte model. Although the effect of CT peptide on Ca 2ϩ release from IP 3 -sensitive Ca 2ϩ stores must be confirmed in the neuronal system, our results support further the view that the CT peptide plays an important role in pathogenesis of AD (56, 57) . The inhibitory effect of CT on IP 3 -sensitive Ca 2ϩ release could disrupt intracellular Ca 2ϩ homeostasis and thus contribute to the cellular toxicity in AD.
